Prostate cancer susceptibility loci: Finding the genes

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 179-190

  Ostrander, Elanie A ^a   Johannesson, Bo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 22; CLINICAL FEATURE; CONFERENCE PAPER; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; GLEASON SCORE; HUMAN; KIDNEY CANCER; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; SEGREGATION ANALYSIS; TUMOR GENE; GENE; GENETICS; MALE; PHYSIOLOGY; PROSTATE TUMOR; REVIEW;

GENES; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 46749138735     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_17     Document Type: Conference Paper

References (75)

1. Jemal A, Siegel R, Ward E, et al. (2006) Cancer Statistics, 2006. CA Cancer J Clin, 56: 106-130.
2. Ries L, Harkins D, Krapcho M, et al. (2005) SEER Cancer Statistics Review, 1975-2003. Bethesda MD: National Cancer Institute.
3. Wingo PA, Bolden S, Tong T, et al. (1996) Cancer statistics for African Americans, 1996. CA Cancer J Clin, 46: 113-125.
4. Walker B, Figgs LH, Zahm S (1995) Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect, 103: 275-182.
5. Carter BS, Beaty TH, Steinberg GD, et al. (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA, 89: 3367-3371.
6. Schaid DJ, McDonnell SK, Blute ML, et al. (1998) Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet, 62: 1425-1438.
7. Grönberg H, Damber L, Damber, JE, et al. (1997) Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance. Am J Epidemiol, 146: 552-557.
8. Cui J, Staples MP, Hopper JL, et al. (2001) Segregation analyses of 1,476 population-based australian families affected by prostate cancer. Am J Hum Genet, 68: 1207-1218.
9. Stanford JL, Ostrander EA (2001) Familial prostate cancer. Epidemiol Rev, 23: 19-23.
10. Steinberg GD, Carter BS, Beaty TH, et al. (1990) Family history and the risk of prostate cancer. Prostate, 17: 337-347.
11. Cannon L, Bishop DT, Skolnick M, et al. (1982) Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv, 1: 47-69.
12. Page WF, Braun MM, Partin AW, et al. (1997) Heredity and prostate cancer: a study of World War II veteran twins. Prostate, 33: 240-245.
13. Lichtenstein P, Holm NV, Verkasalo PK, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland [see comments]. N Engl J Med, 343: 78-85.
14. Smith JR, Freije D, Carpten JD, et al. (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science, 274: 1371-1374.
15. Suarez BK, Lin J, Burmester JK, et al. (2000) A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet, 66: 933-944.
16. Gibbs M, Stanford JL, Jarvik GP, et al. (2000) A genomic scan of families with prostate cancer identifies multiple regions of interest. Am J Hum Genet, 67: 100-109.
17. Suarez BK, Lin J, Witte JS, et al. (2000) Replication linkage study for prostate cancer susceptibility genes. Prostate, 45: 106-114.
18. Goddard KA, Witte JS, Suarez BK, et al. (2001) M. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet, 68: 1197-1206.
19. Cunningham JM, McDonnell SK, Marks A, et al. (2003) Genome linkage screen for prostate cancer susceptiblity loci: Results from the Mayo Clinic Familial Prostate Cancer Study. Prostate, 57: 335-346.
20. Edwards S, Meitz J, Eles R, et al. (2003) Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium. Prostate, 57: 270-279.
21. Janer M, Friedrichsen DM, Stanford JL, et al. (2003) Genomic scan of 254 hereditary prostate cancer families. Prostate, 57: 309-319.
22. Lange EM, Gillanders EM, Davis CC, et al. (2003) Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate, 57: 326-334.
23. Schleutker J, Baffoe-Bonnie AB, Gillanders E, et al. (2003) Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26. Prostate, 57: 280-289.
24. Wiklund F, Jonsson BA, Goransson I, et al. (2003) Linkage analysis of prostate cancer susceptibility: confirmation of linkage at 8p22-23. Hum Genet, 112: 414-418.
25. Xu J, Gillanders EM, Wiley KE, et al. (2003) Genome-wide scan for prostate cancer susceptilbity genes in the Johns Hopkins Hereditary prostate cancer families. Prostate, 57: 320-325.
26. Matsui H, Suzuki K, Ohtake N, et al. (2004) Genomewide linkage analysis of familial prostate cancer in the Japanese population. J Hum Genet, 49: 9-15.
27. Hsieh CL, Oakley-Girvan I, Balise RR, et al. (2001) A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Am J Hum Genet, 69: 148-158.
28. Gillanders EM, Xu J, Chang BL, et al. (2004) Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst, 96: 1240-1247.
29. Camp NJ, Farnham JM, Cannon Albright LA (2005) Genomic search for prostate cancer predisposition loci in Utah pedigrees. Prostate, 65: 365-374.
30. Xu J, Dimitrov L, Chang BL, et al. (2005) A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet, 77: 219-229.
31. Ostrander EA, Stanford JL (2000) Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet, 67: 1367-1375.
32. Ostrander EA, Markianos K, Stanford JL (2004) Finding prostate cancer susceptibility genes. Annu Rev Genomics Hum Genet, 5: 151-175.
33. Easton DF, Schaid DJ, Whittemore AS, et al. (2003) Where are the prostate cancer genes? A summary of eight genome wide searches. Prostate, 57: 261-269.
34. Verhage BA, Kiemeney LA (2003) Inherited predisposition to prostate cancer. Eur J Epidemiol, 18: 1027-1036.
35. Schaid DJ (2004) The complex genetic epidemiology of prostate cancer. Hum Mol Genet, 13: R103-R121.
36. Carter BS, Bova GS, Beaty TH, et al. (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol, 150: 797-802.
37. Singh R, Eeles RA, Durocher F, et al. (2000) High risk genes predisposing to prostate cancer development-do they exist? Prostate Cancer Prostatic Dis, 3: 241-247.
38. Easton D, Peto J (1990) The contribution of inherited predisposition to cancer incidence. Cancer Surv, 9: 395-416.
39. Nupponen NN, Carpten JD (2001) Prostate cancer susceptibility genes: many studies, many results, no answers. Cancer Metastasis Rev, 20: 155-164.
40. Tavtigian SV, Simard J, Teng DH, et al. (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet, 27: 172-180.
41. Carpten J, Nupponen N, Isaacs S, et al. (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet, 30: 181-184.
42. Xu J, Zheng SL, Carpten JD, et al. (2001) Evaluation of linkage and association of HPC2/ ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet, 68: 901-911.
43. Edwards SM, Kote-Jarai Z, Meitz J, et al. (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet, 72: 1-12.
44. Rokman A, Baffoe-Bonnie AB, Gillanders E, et al. (2005) Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Hum Genet, 116: 43-50.
45. Rennert H, Bercovich D, Hubert A, et al. (2002) A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet, 71: 981-984.
46. Rokman A, Ikonen T, Seppala EH, et al. (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet, 70: 1299-1304.
47. Witte JS, Suarez BK, Thiel B, et al. (2003) Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate, 57: 298-308.
48. Xu J (2000) ICPCG Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet, 66: 945-957.
49. Schaid DJ, Chang BL (2005) Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. Prostate, 63:276-290.
50. Schaid DJ, McDonnell SK, Zarfas KE, et al. (2006) Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet 120:471-85.
51. Ostrander EA, Kwon EM, Stanford JL (2006) Genetic susceptibility to aggressive prostate cancer. Cancer Epidemiol Biomarkers Prev, 15: 1761-1764.
52. Gleason D (1997) Histologic grading and clinical staging of prostatic carcinoma. Philadelphia: Lea and Febiger.
53. Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol, 23: 273-279.
54. Witte JS, Goddard KA, Conti DV, et al. (2000) Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet, 67: 92-99.
55. Neville PJ, Conti DV, Paris PL, et al. (2002) Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. Neoplasia, 4: 424-431.
56. Neville PJ, Conti DV, Krumroy LM, et al. (2003) Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer, 36: 332-339.
57. Paiss T, Worner S, Kurtz F, et al. (2003) Linkage of aggressive prostate cancer to chromosome 7q31-33 in German prostate cancer families. Eur J Hum Genet, 11: 17-22.
58. Slager SL, Schaid DJ, Cunningham JM, et al. (2003) Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet, 72: 759-762.
59. Slager SL, Zarfas KE, Brown WM, et al. (2006) Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project. Prostate, 66: 173-179.
60. Chang B, Isaacs S, Wiley K, et al. (2005) Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease. Prostate, 64: 356-361.
61. Stanford JL, McDonnell SK, Friedrichsen DM, et al. (2006) Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. Prostate, 66: 317-325.
62. Johanneson B, Deutsch K, McIntosh L, et al. Suggestive genetic linkage to chromosome 11q12.1 in hereditary prostate cancer families with primary kidney cancer. Prostate (in press).
63. Gronberg H, Bergh A, Damber JE, et al. (2000) Cancer risk in families with hereditary prostate carcinoma. Cancer, 89: 1315-1321.
64. Vaittinen P, Hemminki K (1999) Familial cancer risks in offspring from discordant parental cancers. Int J Cancer, 81: 12-19.
65. Amundadottir LT, Sulem P, Gudmundsson J, et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet, 38: 652-658.
66. Eldon BJ, Jonsson E, Tomasson J, et al. (2003) Familial risk of prostate cancer in Iceland. BJU Int, 92: 915-919.
67. Jonsson E, Sigbjarnarson HP, Tomasson J, et al. (2006) Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987. Scand J Urol Nephrol, 40: 265-271.
68. Rokman A, Baffoe-Bonnie AB, Gillanders E, et al. (2005) Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Hum Genet, 116: 43-50.
69. Hamel N, Kotar K, Foulkes WD (2003) Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer. BMC Med Genet, 4: 7.
70. Orr-Urtreger A, Bar-Shira A, Bercovich D, et al. (2006) RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. Cancer Epidemiol Biomarkers Prev, 15: 474-479.
71. Poynter JN, Cooney KA, Bonner JD, et al. (2006) APC I1307K and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 15: 468-473.
72. Bar-Shira A, Matarasso N, Rosner S, et al. (2006) Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6. Prostate, 66: 1052-1060.
73. Dagan E, Laitman Y, Levanon N, et al. (2006) The 471delAAAG Mutation and C353T Polymorphism in the RNASEL Gene in Sporadic and Inherited Cancer in Israel. Fam Cancer, 31: 31.
74. Friedrichsen DM, Stanford JL, Isaacs SD, et al. (2004) Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families. Proc Natl Acad Sci USA, 101: 1939-1944.
75. Cook Jr, EH (2002) Merlin: faster linkage analysis with improved genotyping error detection. Pharmacogenomics J, 2: 139-140.